Human IL-1β Antibody

Mouse IgG1 (clone 4H5) - Hybridoma

ABOUT

Neutralizing monoclonal antibody against human interleukin 1 beta

Anti-hIL-1β-IgG (clone 4H5) is a monoclonal antibody (mAb) specific for human interleukin 1 beta (hIL-1β). It is produced in hybridomas and purified by affinity chromatography. This antibody has been selected for its ability to efficiently neutralize the biological activity of hIL-1β.
IL-1β is a soluble pro-inflammatory cytokine that plays a critical role in the host response to infection and injury [1]. 

More details More details

 

Key features:

  • A potent and specific neutralizing mAb against hIL-1β
  • Provided azide-free
  • No cross-reactivity with human IL-1α, murine IL-1α, or murine IL-1β
  • Each lot is functionally tested

 

Reference:

1. Dinarello C., 2018. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 281(1): 8–27. 

All products are for research use only, and not for human or veterinary use.

SPECIFICATIONS

Specifications

Target

IL-1β

Target species

Human

Species
Human
Isotype
mIgG1
kappa
Clone
4H5
Tag
Tag-free
Source
Hybridoma
Purification
Protein A
Formulation buffer

Sodium phosphate buffer, glycine, saccharose, stabilizing agents

Preservative
Azide-free
Appearance (form)
Lyophilized
Reconstitution buffer
Sterile water (not provided)
Endotoxin

Negative (tested using EndotoxDetect™ assay)

Tested applications

Neutralization assay

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: 
    Anti-hIL-1β-IgG
  • Cat code: 
    mabg-hil1b-3
  • Quantity: 
    3 x 100 µg

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • -20 °C
    Stability: -20°C for up to 1 year

    Caution:

    • Avoid repeated freeze-thaw cycles

Details

Interleukin-1 beta (IL-1β) is a secreted pro-inflammatory cytokine [1]. It participates in the generation of systemic and local responses to infection and injury [2]. IL-1β is produced by activated macrophages as a pro‑protein, which is cleaved by caspase 1, an enzyme that is activated within the inflammasome multiprotein complex [3].
The resulting mature IL-1β is secreted and binds to the IL-1RI receptor triggering the formation of the IL-1R1/IL-1R3/MyD88 complex and inducing MyD88‑mediated intracellular signaling. This leads to the activation of the transcription factor NK-κB signaling, and the JNK and p38 mitogen‑activated protein kinase pathways, which induce the expression of inflammatory cytokines and chemokines, such as IL-6 and IL-8 [4].
 

1. Dinarello C., 2018. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 281(1): 8-27.
2. Sims J. & Smith D., 2010. The IL-1 family: regulators of immunity. Nat Rev Immunol. 10(2):89-102.
3. O’Neill L., 2008. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226:10–18.
4. Weber A. et al., 2010. Interleukin-1 (IL-1) pathway. Sci Signal. 3(105):cm1.

DOCUMENTS

Documents

Anti-hIL-1β-IgG

Technical Data Sheet

Safety Data Sheet

Validation Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?